1. Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J. 2020;56(4):2002554. [
DOI:10.1183/13993003.02554-2020] [
PMID] [
PMCID]
2. Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Annals of Intensive Care. 2020;10(1):1-4. [
DOI:10.1186/s13613-020-00686-4] [
PMID] [
PMCID]
3. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Science Translational Medicine. 2012;4(165):165rv13. [
DOI:10.1126/scitranslmed.3004404] [
PMID]
4. Abad A, Fernández-Molina JV, Bikandi J, Ramírez A, Margareto J, Sendino J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Revista iberoamericana de micologia. 2010;27(4):155-82. [
DOI:10.1016/j.riam.2010.10.003] [
PMID]
5. Obar JJ. Sensing the threat posed by Aspergillus infection. Current Opinion in Microbiology. 2020;58:47-55. [
DOI:10.1016/j.mib.2020.08.004] [
PMID]
6. Fontaine T, Latgé J-P. Galactomannan Produced by Aspergillus fumigatus: An Update on the Structure, Biosynthesis and Biological Functions of an Emblematic Fungal Biomarker. Journal of Fungi. 2020;6(4):283. [
DOI:10.3390/jof6040283] [
PMID] [
PMCID]
7. Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. British journal of haematology. 2010;150(4):406-17. [
DOI:10.1111/j.1365-2141.2010.08283.x] [
PMID]
8. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS pathogens. 2006;2(12). [
DOI:10.1371/journal.ppat.0020129] [
PMID] [
PMCID]
9. Latge J-P, Chamilos G. Aspergillus fumigatus and aspergillosis in 2019. Clinical microbiology reviews. 2019;33(1). [
DOI:10.1128/CMR.00140-18] [
PMID] [
PMCID]
10. Deshmukh H, Rambach G, Sheppard DC, Lee M, Hagleitner M, Hermann M, et al. Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation. Microbes and Infection. 2020. [
DOI:10.1016/j.micinf.2019.12.004] [
PMID]
11. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. Journal of interferon & cytokine research. 2002;22(9):913-22. [
DOI:10.1089/10799900260286623] [
PMID]
12. Page C. Platelets as inflammatory cells. Immunopharmacology. 1989;17(1):51-9. [
DOI:10.1016/0162-3109(89)90008-8]
13. Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, et al. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. Journal of Infectious Diseases. 2008;198(8):1243-6. [
DOI:10.1086/591458] [
PMID] [
PMCID]
14. Perkhofer S, Striessnig B, Sartori B, Hausott B, Ott HW, Lass-Flörl C. Interaction of platelets and anidulafungin against Aspergillus fumigatus. Antimicrobial agents and chemotherapy. 2013;57(1):626-8. [
DOI:10.1128/AAC.01534-12] [
PMID] [
PMCID]
15. Perkhofer S, Trappl K, Nussbaumer W, Dierich MP, Lass-Flörl C. Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. Journal of Antimicrobial Chemotherapy. 2010;65(6):1309-11. [
DOI:10.1093/jac/dkq111] [
PMID]
16. Tischler BY, Tosini NL, Cramer RA, Hohl TM. Platelets are critical for survival and tissue integrity during murine pulmonary Aspergillus fumigatus infection. PLoS pathogens. 2020;16(5):e1008544. [
DOI:10.1371/journal.ppat.1008544] [
PMID] [
PMCID]
17. Speth C, Rambach G, Lass-Florl C. Platelet immunology in fungal infections. Thrombosis and haemostasis. 2014;112(4):632-9. [
DOI:10.1160/TH14-01-0074] [
PMID]
18. Verschoor A, Langer HF. Crosstalk between platelets and the complement system in immune protection and disease. Thrombosis and haemostasis. 2013;110(5):910-9. [
DOI:10.1160/TH13-02-0102] [
PMID]
19. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clinical microbiology reviews. 2009;22(3):447-65. [
DOI:10.1128/CMR.00055-08] [
PMID] [
PMCID]
20. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nature Reviews Microbiology. 2006;4(6):445-57. [
DOI:10.1038/nrmicro1425] [
PMID]
21. Yeaman MR, Puentes S, Norman D, Bayer A. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infection and immunity. 1992;60(3):1202-9. [
DOI:10.1128/IAI.60.3.1202-1209.1992] [
PMID] [
PMCID]
22. Robert R, Mahaza C, Miegeville M, Ponton J, Marot-Leblond A, Senet J-M. Binding of resting platelets to Candida albicans germ tubes. Infection and immunity. 1996;64(9):3752-7. [
DOI:10.1128/IAI.64.9.3752-3757.1996] [
PMID] [
PMCID]
23. Tang Y-Q, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infection and immunity. 2002;70(12):6524-33. [
DOI:10.1128/IAI.70.12.6524-6533.2002] [
PMID] [
PMCID]
24. Casanova M, Lopez-Ribot J, Martinez J, Sentandreu R. Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques. Infection and immunity. 1992;60(11):4898-906. [
DOI:10.1128/IAI.60.11.4898-4906.1992] [
PMID] [
PMCID]
25. Perkhofer S, Niederegger H, Blum G, Burgstaller W, Ledochowski M, Dierich MP, et al. Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. International journal of antimicrobial agents. 2007;29(4):424-9. [
DOI:10.1016/j.ijantimicag.2006.12.003] [
PMID] [
PMCID]
26. Perkhofer S, Trappl K, Nussbaumer W, Dierich MP, Lass-Flörl C. Potential synergistic activity of antimycotic substances in combination with human platelets against. 2010. [
DOI:10.1093/jac/dkq111] [
PMID]
27. Sepahi S, Pasdar A, Gerayli S, Rostami S, Gholoobi A, Meshkat Z. CTLA-4 gene haplotypes and the risk of chronic hepatitis C infection; a case control study. Reports of Biochemistry & Molecular Biology. 2017;6(1):51.
28. Jamaati H, Bahrami N, Daustany M, Tabarsi P, Farzanegan B, Hashemian SM, et al. Investigating PIK3R3 and ATp2A1 Genes Expressions in Ventilator-Associated Pneumonia Patients Admitted to the Intensive Care Unit of Masih Daneshvari Hospital in 2016. Reports of biochemistry & molecular biology. 2018;6(2):118.
29. Steenwyk JL, Mead ME, Knowles SL, Raja HA, Roberts CD, Bader O, et al. Variation Among Biosynthetic Gene Clusters, Secondary Metabolite Profiles, and Cards of Virulence Across Aspergillus Species. Genetics. 2020;216(2):481-97. [
DOI:10.1534/genetics.120.303549] [
PMID]
30. Ries LN, Pardeshi L, Dong Z, Tan K, Steenwyk JL, Colabardini AC, et al. The Aspergillus fumigatus transcription factor RglT is important for gliotoxin biosynthesis and self-protection, and virulence. PLoS pathogens. 2020;16(7):e1008645. [
DOI:10.1371/journal.ppat.1008645] [
PMID] [
PMCID]
31. Sugui JA, Kim HS, Zarember KA, Chang YC, Gallin JI, Nierman WC, et al. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One. 2008;3(7). [
DOI:10.1371/journal.pone.0002655] [
PMID] [
PMCID]
32. Morton CO, Varga JJ, Hornbach A, Mezger M, Sennefelder H, Kneitz S, et al. The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro. PloS one. 2011;6(1). [
DOI:10.1371/journal.pone.0016016] [
PMID] [
PMCID]
33. Oosthuizen JL, Gomez P, Ruan J, Hackett TL, Moore MM, Knight DA, et al. Dual organism transcriptomics of airway epithelial cells interacting with conidia of Aspergillus fumigatus. PLoS One. 2011;6(5). [
DOI:10.1371/journal.pone.0020527] [
PMID] [
PMCID]
34. Perkhofer S, Zenzmaier C, Frealle E, Blatzer M, Hackl H, Sartori B, et al. Differential gene expression in Aspergillus fumigatus induced by human platelets in vitro. International Journal of Medical Microbiology. 2015;305(3):327-38. [
DOI:10.1016/j.ijmm.2015.01.002] [
PMID] [
PMCID]
35. Perkhofer S, Kainzner B, Kehrel BE, Dierich MP, Nussbaumer W, Lass-Flörl C. Potential antifungal effects of human platelets against zygomycetes in vitro. The Journal of infectious diseases. 2009;200(7):1176-9. [
DOI:10.1086/605607] [
PMID] [
PMCID]
36. Zacharias CA, Sheppard DC. The role of Aspergillus fumigatus polysaccharides in host-pathogen interactions. Current opinion in microbiology. 2019;52:20-6. [
DOI:10.1016/j.mib.2019.04.006] [
PMID]
37. Walsh TJ, Petraitiene R, Petraitis V. Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets? Journal of Fungi. 2020;6(4):198. [
DOI:10.3390/jof6040198] [
PMID] [
PMCID]
38. McDonagh A, Fedorova ND, Crabtree J, Yu Y, Kim S, Chen D, et al. Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS pathogens. 2008;4(9). [
DOI:10.1371/journal.ppat.1000154] [
PMID] [
PMCID]
39. Millet N, Moya‐Nilges M, Sachse M, Krijnse Locker J, Latgé JP, Mouyna I. Aspergillus fumigatus exoβ (1‐3) glucanases family GH55 are essential for conidial cell wall morphogenesis. Cellular microbiology. 2019;21(12):e13102. [
DOI:10.1111/cmi.13102] [
PMID]
40. Mouyna I, Hartl L, Latgé J-P. β-1, 3-glucan modifying enzymes in Aspergillus fumigatus. Frontiers in microbiology. 2013;4:81. [
DOI:10.3389/fmicb.2013.00081] [
PMID] [
PMCID]
41. Rodland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, et al. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun. 2010;78(3):1269-75. [
DOI:10.1128/IAI.01091-09] [
PMID] [
PMCID]
42. Stergiopoulou T, Meletiadis J, Roilides E, Kleiner DE, Schaufele R, Roden M, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. American journal of clinical pathology. 2007;127(3):349-55. [
DOI:10.1309/UJRV9DLC11RM3G8R] [
PMID]
43. Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Műller F, Aukrust P, et al. Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infection and immunity. 2010;78(3):1269-75. [
DOI:10.1128/IAI.01091-09] [
PMID] [
PMCID]